Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors
- PMID: 11141566
- DOI: 10.1126/science.291.5501.134
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors
Retraction in
-
Retraction.Science. 2002 Dec 20;298(5602):2327. doi: 10.1126/science.298.5602.2327b. Science. 2002. PMID: 12526115 No abstract available.
Abstract
Most traditional cytotoxic anticancer agents ablate the rapidly dividing epithelium of the hair follicle and induce alopecia (hair loss). Inhibition of cyclin-dependent kinase 2 (CDK2), a positive regulator of eukaryotic cell cycle progression, may represent a therapeutic strategy for prevention of chemotherapy-induced alopecia (CIA) by arresting the cell cycle and reducing the sensitivity of the epithelium to many cell cycle-active antitumor agents. Potent small-molecule inhibitors of CDK2 were developed using structure-based methods. Topical application of these compounds in a neonatal rat model of CIA reduced hair loss at the site of application in 33 to 50% of the animals. Thus, inhibition of CDK2 represents a potentially useful approach for the prevention of CIA in cancer patients.
Comment in
-
Cancer research. Preventing hair loss from chemotherapy.Science. 2001 Jan 5;291(5501):25-6. doi: 10.1126/science.10.1126/science.291.5501.25a. Science. 2001. PMID: 11191992 No abstract available.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources